← All trials
NCT00546000
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2007
- Primary completion
- Dec 1, 2008
- Completion date
- Dec 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 56
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- FougeraLead sponsor
- University of MiamiOverall official - principal investigator
- University of Texas at HoustonOverall official - principal investigator
- University of California, San DiegoOverall official - principal investigator
- University of Texas, GalvestonOverall official - principal investigator
- Adult & Pediatric DermatologyOverall official - principal investigator
- Wake Forest UniversityOverall official - principal investigator
- Paddington Testing CompanyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.